Odyssey Therapeutics, Inc. (ODTX)
25.17
-1.22
(-4.62%)
USD |
NASDAQ |
Aug 24, 16:00
25.17
0.00 (0.00%)
After-Hours: 19:19
Odyssey Therapeutics Shareholders Equity (Quarterly) : 421.22M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 421.22M |
| March 31, 2026 | -523.69M |
| June 30, 2025 |
| Date | Value |
|---|---|
| March 31, 2025 | |
| December 31, 2024 | 132.37M |
| December 31, 2023 | 225.50M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 483.85M |
| Total Liabilities (Quarterly) | 62.63M |
| Debt to Equity Ratio | 0.0589 |
| Current Ratio | 11.36 |
| Net Debt Paydown Yield | 0.21% |